The consistent upregulation of miR-106b-5p in ESCC tissues and its promotion of key oncogenic processes such as proliferation, invasion, and metastasis through multiple targets (PTEN, SMAD-7, HPGD) make it a promising target for therapeutic intervention in ESCC. Here, SMAD7 is linked to esophageal squamous cell carcinoma.